IL291025B2
Pharmaceutical agent for inducing specific immunity against sars-cov-2
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO0166137A1 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-8 |
| WO2006086284A2 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-8 |
| WO2007104792A2 | Cites | World Intellectual Property Organization (WIPO) | Y | Search report | 1-8 |
| RU2720614C1 | Cites | Russian Federation | Y | Search report | 1-8 |
| ABBINK, PETER, ET AL., COMPARATIVE SEROPREVALENCE AND IMMUNOGENICITY OF SIX RARE SEROTYPE RECOMBINANT ADENOVIRUS VACCINE VECTORS FROM SUBGROUPS B AND D., 1 May 2007 (2007-05-01) | Non-patent | – | – | Search report | – |
| TATSIS, NIA, AND HILDEGUND CJ ERTL., ADENOVIRUSES AS VACCINE VECTORS., 14 August 2004 (2004-08-14) | Non-patent | – | – | Search report | – |
3 priority claims, no other members on record
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 2020127980 | Russian Federation | – | |
| 2020127980 | Russian Federation | A | |
| 2020000591 | Russian Federation | W |
Numbers
- Publication
- 291025
- Application
- 291025
Titles2
- English
- PHARMACEUTICAL AGENT FOR INDUCING SPECIFIC IMMUNITY AGAINST SARS-COV-2
- Hebrew
- סוכן תרופות לגרימת חסינות ספציפית נגד SARS-COV-2
Classification
- CPC, 20
- A61K39/215
- A61P31/14
- C12N15/86
- C12N7/00
- A61K39/12
- A61K2039/53
- C07K14/005
- C12N2710/10343
- C12N2770/20022
- C12N2770/20034
- A61K9/08
- A61K9/19
- A61K47/02
- A61K47/18
- A61K47/183
- A61K47/26
- C12N2710/10045
- A61K2039/575
- A61K47/10
- C12N2710/10371
- IPC, 5
- A61K39 00
- C12N15 86
- C07K14 005
- A61P31 14
- A61K39 12